Wednesday, October 4, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from 
Steering Committee Chair
Full Professor of Hygiene and Public Health
University Vita-Salute San Raffaele
Milan, Italy
Scientific Director
Cardiovascular Research Area. i+12 Research Institute
Cardiology Department
Hospital Universitario 12 de Octubre
Universidad Complutense de Madrid Madrid, Spain
General Practitioner
National Immunization Lead
Royal College of General Practitioners
President
British Global and Travel Health Association
London, United Kingdom
President
Infectious Disease Society of São Paulo
Emilio Ribas Infectious Diseases Institute
São Paulo, Brazil
Head, Translational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clinico Universitario de Santiago de Compostela; Coordinator of Genetics Vaccines Infections and Pediatrics Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
Director of Research
CNR Aging Branch-Institute of Neuroscience,
Director of the CNR Project on Ageing
Padua, Italy
Steering Committee Chair
Has disclosed no relevant financial relationships.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Novartis Pharmaceuticals Corporation
Received grants for clinical research from: AstraZeneca Pharmaceuticals LP; Bayer HealthCare; PhaseBio; Novartis Pharmaceuticals Corporation
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Merck Sharp & Dohme Corp; Sanofi Pasteur; Seqirus
Served as a speaker or a member of a speakers bureau for: AstraZeneca Pharmaceuticals LP; Merck Sharp & Dohme Corp; Sanofi Pasteur; Seqirus; Valneva
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AstraZeneca Pharmaceuticals LP; Merck Sharp & Dohme Corp; Pfizer Inc.; Sanofi; Takeda Pharmaceuticals North America, Inc.
Served as a speaker or a member of a speakers bureau for: Merck Sharp & Dohme Corp; Pfizer Inc.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biofabri; GlaxoSmithKline; Janssen Pharmaceuticals; MedImmune Inc.; Merck Sharp & Dohme Corp; Novavax, Inc.; Pfizer Inc.; Sanofi Pasteur; Seqirus
Served as a speaker or a member of a speakers bureau for: GlaxoSmithKline; Merck Sharp & Dohme Corp; Pfizer Inc.; Sanofi Pasteur; Seqirus
Received grants for clinical research from: GlaxoSmithKline; Merck Sharp & Dohme Corp; Pfizer Inc.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: GlaxoSmithKline; Pfizer Inc.
Served as a speaker or a member of a speakers bureau for: GlaxoSmithKline; Mylan Laboratories Inc.; Pfizer Inc.; Sanofi
Received grants for clinical research from: Sanofi